Turn Therapeutics (TTRX) Amortizatization of Intangibles (2025 - 2026)

Turn Therapeutics' (TTRX) quarterly Amortizatization of Intangibles came in at $14451.0 in Q1 2026, up 16.33% year-on-year from $12422.0 in Q1 2025, and up 16.33% quarter-over-quarter from $12422.0 in Q1 2025.

Turn Therapeutics (TTRX) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Turn Therapeutics' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $14451.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 3.22 Mn
10 Turn Therapeutics 253.20 Mn 253.20 Mn - 14,451.00

Historic Data

Download Data
DateValue
Mar 31, 2026 14,451.00
Mar 31, 2026 14,451.00
Mar 31, 2025 12,422.00
Mar 31, 2025 12,422.00